Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Axonal degeneration in multiple sclerosis: defining therapeutic targets by identifying the causes of pathology.
Involvement of CD8(+) T Cells in Multiple Sclerosis.
Safety, anxiety and natalizumab continuation in JC virus-seropositive MS patients.
Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II).
Predicting relapsing-remitting dynamics in multiple sclerosis using discrete distribution models: a population approach.
Inhibitory saccadic dysfunction is associated with cerebellar injury in multiple sclerosis.
Efficacy and safety of natalizumab treatment for relapsing-remitting multiple sclerosis: interim results of the tysabri(r) observational programme in the uk.
Radiologically isolated syndrome: an uncommon finding at a university clinic in a high-prevalence region for multiple sclerosis.
Selectins and their ligands as potential immunotherapeutic targets in neurological diseases.
Anti-myelin antibodies play an important role in the susceptibility to develop PLP-induced EAE.
T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis.
Visual search as a tool for a quick and reliable assessment of cognitive functions in patients with multiple sclerosis.
Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosis.
Exercise training improves depressive symptoms in people with multiple sclerosis: Results of a meta-analysis.
Benefits versus risks of latest therapies in multiple sclerosis: a perspective review.
Molecular mechanisms of scar-sourced axon growth inhibitors.
Panic disorder as presenting symptoms of multiple sclerosis.
Regression to the Mean and Predictors of MRI Disease Activity in RRMS Placebo Cohorts - Is There a Place for Baseline-to-Treatment Studies in MS?
Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis.
Effects of isoxazolo-pyridinone 7e, a potent activator of the nurr1 signaling pathway, on experimental autoimmune encephalomyelitis in mice.
RNA sequencing of microglia and monocyte-derived macrophages from mice with experimental autoimmune encephalomyelitis illustrates a changing phenotype with disease course.
SPECIFIC TARGETING OF THE IL-23 RECEPTOR USING A NOVEL SMALL PEPTIDE NON-COMPETITIVE ANTAGONIST, DECREASES THE INFLAMMATORY RESPONSE.
Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE.
Role of Hemichannels in CNS Inflammation and the Inflammasome Pathway.

Pages